- Report
- May 2024
- 134 Pages
From €6184EUR$6,499USD£5,295GBP
- Report
- May 2024
- 133 Pages
From €6184EUR$6,499USD£5,295GBP
- Report
- May 2024
- 134 Pages
From €6184EUR$6,499USD£5,295GBP
- Report
- May 2024
- 128 Pages
From €6184EUR$6,499USD£5,295GBP
- Report
- May 2024
- 131 Pages
From €6184EUR$6,499USD£5,295GBP
- Report
- May 2024
- 128 Pages
From €6184EUR$6,499USD£5,295GBP
- Report
- April 2023
- 275 Pages
Global
From €3796EUR$3,990USD£3,251GBP
- Report
- January 2021
Global
From €3030EUR$3,185USD£2,595GBP
€4329EUR$4,550USD£3,707GBP
- Report
- October 2022
- 216 Pages
Middle East
From €1998EUR$2,100USD£1,711GBP
€2854EUR$3,000USD£2,444GBP
- Report
- December 2021
- 191 Pages
Global
From €3030EUR$3,185USD£2,595GBP
€4329EUR$4,550USD£3,707GBP
From €1998EUR$2,100USD£1,711GBP
€2854EUR$3,000USD£2,444GBP
From €1998EUR$2,100USD£1,711GBP
€2854EUR$3,000USD£2,444GBP
- Report
- May 2021
Asia Pacific
From €1998EUR$2,100USD£1,711GBP
€2854EUR$3,000USD£2,444GBP
- Report
- May 2021
North America
From €1998EUR$2,100USD£1,711GBP
€2854EUR$3,000USD£2,444GBP
- Report
- May 2021
Middle East, Africa
From €1998EUR$2,100USD£1,711GBP
€2854EUR$3,000USD£2,444GBP
- Report
- April 2023
- 115 Pages
Global
From €4519EUR$4,750USD£3,870GBP
- Report
- February 2023
- 220 Pages
Global
From €7136EUR$7,500USD£6,110GBP
- Report
- February 2022
- 220 Pages
Global
From €9039EUR$9,500USD£7,739GBP
- Report
- April 2023
- 115 Pages
Global
From €4519EUR$4,750USD£3,870GBP
- Report
- April 2023
- 120 Pages
Global
From €4519EUR$4,750USD£3,870GBP
The anticoagulant market within the context of cardiovascular drugs is a rapidly growing sector of the pharmaceutical industry. Anticoagulants are drugs used to prevent the formation of blood clots, which can lead to serious medical conditions such as stroke and heart attack. These drugs are used to reduce the risk of thrombosis, a condition in which a blood clot forms in a blood vessel, blocking the flow of blood. Anticoagulants are also used to treat existing blood clots, as well as to prevent the formation of new ones.
The anticoagulant market is driven by the increasing prevalence of cardiovascular diseases, such as coronary artery disease, stroke, and peripheral artery disease. The rising demand for anticoagulants is also driven by the increasing aging population, as well as the increasing awareness of the importance of preventive healthcare.
Some of the major companies in the anticoagulant market include Bayer AG, Bristol-Myers Squibb, Pfizer, Sanofi, and Johnson & Johnson. These companies are engaged in the development, manufacture, and marketing of anticoagulant drugs. Show Less Read more